Výsledky vyhledávání - "David E. Wheadon"

Double-Blind, Fixed-Dose, Placebo-Controlled Study of Paroxetine in the Treatment of Panic Disorder

Autor: James C. Ballenger, David E. Wheadon, Martin Steiner, I. Gergel, William Bushnell

Publikováno v: American Journal of Psychiatry. 155:36-42

This study was designed to determine the minimum paroxetine dose effective for treating panic disorder.Of 425 patients with DSM-III-R panic disorder with or without agoraphobia who underwent a 2-week drug-free screening period, 278 patients were rand

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::423b6072b367b13aa37a539c65f31e7e
https://doi.org/10.1176/ajp.155.1.36

Zobrazit plný text záznamu

Fluoxetine: no association with suicidality in obsessive-compulsive disorder

Autor: Charles M. Beasley, Janet H. Potvin, Laura A. Genduso, David E. Wheadon, Daniel N. Masica, Bruce E. Dornseif

Publikováno v: Journal of Affective Disorders. 24:1-10

Since (a) obsessive-compulsive disorder (OCD) may involve serotonergic neural transmission abnormalities also thought to be related to regulation of suicide and aggression, (b) comorbidity between OCD and depression is substantial, and (c) depression

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f4e9608d0b0b3ef576629a0e46a65e6
https://doi.org/10.1016/0165-0327(92)90054-a

Zobrazit plný text záznamu

Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine

Autor: Rosemary Oakes, David E. Wheadon, Martin Steiner, D. Burnham, Andrea Allen, Eric Hollander

Publikováno v: The Journal of clinical psychiatry. 64(9)

Background: Limited information is available regarding optimal dosing or long-term pharmacotherapy with serotonin reuptake inhibitors in obsessive-compulsive disorder. This study evaluated the acute safety and efficacy and long-term efficacy, safety,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea05f7bc0638e78664b8d219d9db142
https://pubmed.ncbi.nlm.nih.gov/14628989

Zobrazit plný text záznamu

Market Exclusivity for Biologics

Autor: David E Wheadon

Publikováno v: New England Journal of Medicine. 362:661-662

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae3aa9a315b401481e4a6878f4b59b6f
https://doi.org/10.1056/nejmc0912463

Zobrazit plný text záznamu

Possible Monoamine Oxidase Inhibitor-Serotonin Uptake Inhibitor Interaction

Autor: Daniel N. Masica, Chaeles M. Beasley, David E. Wheadon, Robert L. Zerbe, John H. Heiligenstein

Publikováno v: Journal of Clinical Psychopharmacology. 13:312

The primary objective of this article is to review information pertinent to and emphasize the seriousness of a potential adverse monoamine oxidase inhibitor (MAOI)-serotonin uptake inhibitor interaction by considering, within the context of preclinic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::98a5d101c6e431c7cf8c8f528a26df0b
https://doi.org/10.1097/00004714-199310000-00003

Zobrazit plný text záznamu

Dysregulation of hypothalamic-pituitary-adrenal axis function in depressed alcoholic patients

Autor: Steven D. Targum, Mohan T. Advani, C. Terrence Chastek, William J. McCabe, David E. Wheadon

Publikováno v: Journal of Affective Disorders. 4:347-353

Hypothalamic-pituitary-adrenal (HPA) axis function was examined in 28 hospitalized, withdrawing alcoholic patients. Fourteen patients met DSM-III criteria for Major Depressive Disorder. Elevated 8 a.m. basal cortisols were noted in 7 depressed alcoho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fc638990166d077c9eddfdd1b108fc3
https://doi.org/10.1016/0165-0327(82)90030-1

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání